Integrative Skin Science and Research

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Integrative Skin Science and Research sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).

15 total trials 5 currently recruiting 8 completed later-stage tilt top decile by trial count

Integrative Skin Science and Research: 15 sponsored US clinical trials, 5 recruiting.

Integrative Skin Science and Research sponsors 15 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 8 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hyperpigmentation, with 2 trials.

Top-decile sponsor footprint

Integrative Skin Science and Research ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

15 total, page 1 of 1

RECRUITING Phase 4

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

NCT07544251

RECRUITING NA

The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles

NCT06571721

RECRUITING NA

Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea

NCT06072066

RECRUITING NA

The Effects of Almond on Facial Skin Collagen and Wrinkles

NCT06074276

RECRUITING NA

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

NCT05942248

ACTIVE NOT RECRUITING NA

The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome

NCT06146166

NOT YET RECRUITING Phase 4

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

NCT07560618

COMPLETED NA

The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation

NCT06080035

COMPLETED NA

The Effects of Oral Probiotics and Herbal Supplementation on the Gut Microbiome and Sebum Excretion Rate in Non-Cystic Acne

NCT05919810

COMPLETED NA

Prospective Study of Topical Adapinoid Versus Topical Retinol

NCT05778760

COMPLETED NA

The Effect of Isosorbide Diesters Based Moisturizer on Skin Health

NCT04831892

COMPLETED NA

Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties

NCT04596722

COMPLETED NA

The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties

NCT04597502

COMPLETED NA

Topical and Oral Regimen for Skin Health

NCT04872946

COMPLETED NA

Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging

NCT04586816

Phase Distribution

PhaseTrial count
Phase 4 2

Where Integrative Skin Science and Research enrollment is open (later-stage tilt)

5 recruiting of 15 indexed (33% open); 8 completed (53%).

Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Hyperpigmentation (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Integrative Skin Science and Research: open-pipeline peers nationwide

Peers matched on 15 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

Integrative Skin Science and Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%10%20%30%40% Total trials Recruiting share Integrative Skin Science and ResearchAllakosArbor Research Collaborative for HealthArena PharmaceuticalsArrowhead PharmaceuticalsAadi BioscienceAaron CookAbivax S.A.Actuated Medical
Integrative Skin Science and Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Integrative Skin Science and Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 15 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

What to do with this Integrative Skin Science and Research page

15 registered trials is a research-attention snapshot, not an endorsement of Integrative Skin Science and Research or any single study.

  • 5 of Integrative Skin Science and Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hyperpigmentation is the condition Integrative Skin Science and Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hyperpigmentation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Integrative Skin Science and Research pipeline card: 15 registered trials from official public datasets.Report a data error.